Clinical Trial Update: Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids [Phase 4]

View source ↗

Summary

Phase 4 trial assessing omega-3 fatty acids for modulation of esophageal inflammation in Barrett's Esophagus; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Obesity

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Mayo Clinic | Conditions: Barrett's Esophagus, Obesity | Phase 4 | Status: COMPLETED | Results posted: 2022-01-11